Search

Your search keyword '"Jabado, Nada"' showing total 28 results

Search Constraints

Start Over You searched for: Author "Jabado, Nada" Remove constraint Author: "Jabado, Nada" Publication Year Range This year Remove constraint Publication Year Range: This year
28 results on '"Jabado, Nada"'

Search Results

3. Impact of trametinib on the neuropsychological profile of NF1 patients

4. The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial

5. Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial

6. TULIPs decorate the three-dimensional genome of PFA ependymoma

7. Early rhombic lip Protogenin+ve stem cells in a human-specific neurovascular niche initiate and maintain group 3 medulloblastoma

8. Comprehensive Genomic Analysis of Cemento-Ossifying Fibroma

10. Whole‐exome sequencing and copy number alterations analysis in a case of expansive florid cemento‐osseous dysplasia.

11. Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma

13. Abstract B045: Adaptive purine metabolism drives radiation therapy resistance in H3K27M-diffuse midline glioma

14. Abstract B035: A compendium of syngeneic, transplantable pediatric high-grade glioma models reveals subtype-specific therapeutic vulnerabilities

15. Figure 6 from A Compendium of Syngeneic, Transplantable Pediatric High-Grade Glioma Models Reveals Subtype-Specific Therapeutic Vulnerabilities

16. Supplementary Table 6 from A Compendium of Syngeneic, Transplantable Pediatric High-Grade Glioma Models Reveals Subtype-Specific Therapeutic Vulnerabilities

17. Data from A Compendium of Syngeneic, Transplantable Pediatric High-Grade Glioma Models Reveals Subtype-Specific Therapeutic Vulnerabilities

18. Supplementary Table 5 from A Compendium of Syngeneic, Transplantable Pediatric High-Grade Glioma Models Reveals Subtype-Specific Therapeutic Vulnerabilities

19. Supplementary Tables 1-3, 7-9 from A Compendium of Syngeneic, Transplantable Pediatric High-Grade Glioma Models Reveals Subtype-Specific Therapeutic Vulnerabilities

20. Supplementary Table 4 from A Compendium of Syngeneic, Transplantable Pediatric High-Grade Glioma Models Reveals Subtype-Specific Therapeutic Vulnerabilities

21. Supplementary Figures 1-27 from A Compendium of Syngeneic, Transplantable Pediatric High-Grade Glioma Models Reveals Subtype-Specific Therapeutic Vulnerabilities

22. The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial

23. Canadian Consensus for Treatment of BRAF V600E Mutated Pediatric and AYA Gliomas.

26. Immune landscape of oncohistone-mutant gliomas reveals diverse myeloid populations and tumor-promoting function.

27. Comments and Controversies in Oncology: The Tribulations of Trials Developing ONC201.

28. The Virtual Child.

Catalog

Books, media, physical & digital resources